Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Brilacidin is a nonpeptidic anti-infective in a new class of defensin mimetics used for the research of eye infections.
产品描述 | Brilacidin is a nonpeptidic anti-infective in a new class of defensin mimetics used for the research of eye infections. |
体外活性 | Brilacidin is more potent for Gram-positive bacteria (except SV) than Gram-negative bacteria. Brilacidin acts primarily on the bacterial cell membrane by depolarization. Brilacidin has Gram-positive in vitro activity; topical Brilacidin 0.5% is minimally irritating; and Brilacidin 0.5% was equally efficacious as Vancomycin (VAN) in a methicillin-resistant S. aureus (MRSA) keratitis model when the corneal epithelium is removed. Both Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) have the lowest minimum inhibitory concentrations among the bacterial groups. The MIC90s to Brilacidin for Streptococcus pneumonia (SP), Streptococcus viridians (SV), Moraxella (MS), Haemophilus influenza (HI), Pseudomonas aeruginosa (PA), and Serratia marcescens (SM) are 4, 32, 256, 32, 16, and 128-fold higher, respectively than SA and SE. |
体内活性 | Brilacidin (0.5) is determined to be Nonirritating based on their Maximum mean total scores (MMTS) values. Brilacidin 1% is determined to be Mildly Irritating (23.0), Brilacidin 0.5% (6.5), and Brilacidin 0.25% (4.0) are determined to be Minimally Irritating, while Brilacidin 0.1% (2.0) and TBS (1.0) are determined to be Practically Nonirritating and 0.01%. Brilacidin demonstrates dose-dependent ocular toxicity after 7 topical instillations (every 30?min for 3?h) in the NZW rabbit ocular toxicity model. |
别名 | PMX 30063 |
分子量 | 936.91 |
分子式 | C40H50F6N14O6 |
CAS No. | 1224095-98-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Brilacidin 1224095-98-0 Others PMX 30063 PMX-30063 PMX30063 Inhibitor inhibitor inhibit